Serum Biochemistry Interpretation: A Problem-Oriented Approach

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Serum biochemistry interpretation is most effective when approached systematically, focusing on patterns of abnormalities across organ systems and metabolic pathways rather than isolated values. For example, elevated ALT and ALP with hyperbilirubinemia suggests a different diagnostic pathway than an isolated mild ALT elevation.
• Physiological understanding of measurand generation (e.g., enzyme release from cellular damage, metabolite accumulation due to impaired excretion) and clearance is fundamental. For instance, creatinine reflects glomerular filtration, while BUN is influenced by both filtration and hepatic urea synthesis, making it less specific for renal disease.
• Biological variation, including high individuality in certain measurands (e.g., GGT and AST in horses), necessitates the use of subject-based reference intervals and reference change values for accurate serial monitoring, as population-based intervals may not reflect an individual's stable baseline.
• Age-specific reference intervals are critical, particularly in young animals, as significant physiological changes occur in analytes like total protein, phosphorus, AST, and ALP during growth, preventing misinterpretation when adult intervals are applied.
• Differentiating prerenal, renal, and postrenal azotemia relies on integrating biochemical data (BUN, creatinine) with urine specific gravity and urine output, not solely on the magnitude of the azotemia.
• Electrolyte disturbances should be interpreted in conjunction with other electrolytes and acid-base status; for instance, hyponatremia with hyperkalemia in dogs strongly suggests hypoadrenocorticism, warranting an ACTH stimulation test.

Serum biochemistry panels generate a large volume of numerical data, yet the diagnostic value of each measurand depends entirely on the interpretive framework applied. This article provides a problem-oriented approach to serum biochemistry interpretation for practicing veterinarians, emphasizing pattern recognition across organ systems and metabolic pathways. The focus is on common clinical presentations: the jaundiced patient, the azotemic patient, the patient with electrolyte disturbances, and the patient with abnormal muscle or pancreatic enzymes. Individual hormone assays are excluded.

The approach rests on a simple premise: isolated abnormalities are less informative than constellations of abnormalities. A single elevated alanine aminotransferase (ALT) value invites a different differential list than the combination of elevated ALT, elevated alkaline phosphatase (ALP), hyperbilirubinemia, and prolonged clotting times. Pattern recognition requires familiarity with the physiology that generates each measurand, the analytical limitations of the assays, and the biological variation that determines whether a change is clinically meaningful.

Reference intervals are population-based tools, and their limitations are well documented. In horses, several routinely measured biochemistry measurands including total protein, globulins, albumin, gamma-glutamyl transferase, and aspartate aminotransferase demonstrate high individuality, meaning that an individual animal's values may remain stable within a narrow range even when they fall outside the population-based reference interval. The American Society for Veterinary Clinical Pathology publishes quality assurance guidelines that address reference interval methodology and the conditions under which subject-based intervals are preferable. Age-specific reference values are equally important. Holstein calves show significant age-related changes in serum total protein, globulins, inorganic phosphorus, AST, and ALP during the first three months of life, and interpreting calf biochemistry against adult reference intervals produces predictable errors.

At a Glance

Physiological Foundations of Biochemistry Interpretation

Serum biochemistry measures the net balance between cellular production, cellular release, and clearance. Enzymes such as ALT, AST, and creatine kinase (CK) are intracellular proteins that appear in serum when cell membranes are damaged or when cellular turnover increases. The magnitude and time course of enzyme elevation reflect the severity and duration of cellular injury. In contrast, metabolites such as creatinine, urea, and bilirubin accumulate when excretory organ function declines or when production exceeds clearance. Electrolytes and minerals reflect the integrated function of renal tubular transport, gastrointestinal absorption, endocrine regulation, and transcellular shifts.

The liver presents a particular interpretive challenge because it performs both synthetic and excretory functions. Hepatocellular injury releases ALT and AST, cholestasis raises ALP and gamma-glutamyl transferase (GGT), and synthetic failure lowers albumin, urea, and cholesterol. These pathways can be affected independently or together, and the pattern of enzyme and metabolite changes often localizes the disease process more precisely than any single value.

Renal interpretation similarly depends on understanding what each measurand represents. Creatinine is produced at a relatively constant rate from muscle creatine metabolism and is eliminated almost entirely by glomerular filtration. BUN reflects both glomerular filtration and hepatic urea synthesis, making it less specific for renal disease. Electrolyte abnormalities in renal disease arise from tubular dysfunction, which may be disproportionate to the decline in glomerular filtration rate.

Biological Variation and Reference Intervals

Population-based reference intervals assume that a single range can describe the expected values for all individuals within a species. This assumption fails when between-subject variation is large relative to within-subject variation. The index of individuality quantifies this relationship: when the index is low, an individual's values are tightly clustered and may deviate from the population interval without indicating disease. When the index is high, population intervals are more useful for detecting change.

The equine study cited above calculated indices of individuality and reference change values for routine biochemistry measurands. Reference change values describe the magnitude of change between two consecutive measurements that exceeds analytical and biological variation combined. For measurands with high individuality, such as GGT and AST in horses, serial monitoring using reference change values detects disease earlier than comparison with population intervals. The ASVCP quality assurance guidelines provide a framework for implementing these concepts in practice, including recommendations for verifying reference intervals and assessing the analytical performance of in-house analyzers.

Age-specific reference intervals are a second layer of complexity. The calf study demonstrated that serum total protein, globulin, inorganic phosphorus, AST, and ALP change substantially during the first three months of life. Similar age-related changes occur in foals, puppies, and kittens. Applying adult reference intervals to pediatric patients produces false positives for ALP during bone growth and false negatives for globulins during the period of passive transfer and endogenous immunoglobulin production.

The Problem-Oriented Framework

The problem-oriented approach begins with the identification of a biochemical abnormality, proceeds to the generation of a focused differential list, and uses additional measurands to discriminate among possibilities. This framework prevents two common errors: overinterpretation of isolated mild abnormalities and failure to recognize clinically significant patterns.

The first step is always to confirm the abnormality. Analytical error, sample handling, and preanalytical factors produce spurious results. Hemolysis falsely elevates potassium and AST, lipemia interferes with spectrophotometric assays, and delayed serum separation allows cellular enzymes to leak into the sample. Repeat testing is appropriate when the abnormality is unexpected, mild, or inconsistent with the clinical picture.

The second step is to place the abnormality in context. A creatinine of 2.5 mg/dL in a dehydrated dog with concentrated urine suggests prerenal azotemia, while the same value in a hydrated dog with isosthenuric urine indicates renal disease. The third step is to use pattern recognition to narrow the differential list. The sections that follow apply this framework to the major organ systems and metabolic disturbances encountered in practice.

Pattern Recognition in Liver Enzyme Interpretation

The liver enzyme profile is best interpreted as a functional pattern instead of a list of isolated values. The pattern distinguishes hepatocellular injury from cholestasis, and it identifies chronicity, which changes the diagnostic plan.

Hepatocellular Injury Patterns

Marked increases in alanine aminotransferase (ALT) in dogs and cats, or aspartate aminotransferase (AST) and sorbitol dehydrogenase (SDH) in ruminants and horses, indicate hepatocellular damage. The magnitude of the increase correlates loosely with the number of injured hepatocytes, not with the reversibility of the lesion. A dog with parvoviral enteritis and secondary hepatic hypoxia can show ALT activity 10 to 20 times the upper reference limit, yet recover fully. The same increase in a cat with hepatic lipidosis carries a guarded prognosis because the underlying metabolic disturbance persists.

Serial sampling distinguishes ongoing injury from a single insult. ALT activity peaks 24 to 48 hours after an acute hepatocellular event and then declines with a half-life of approximately 60 hours in dogs and 3.5 days in cats. A rising ALT on repeat sampling 48 to 72 hours later indicates continuing injury. A falling ALT with improving clinical signs supports resolving damage. A falling ALT with worsening clinical signs suggests loss of functional hepatocyte mass and carries a poor prognosis.

Cholestatic Patterns

Alkaline phosphatase (ALP) and gamma-glutamyl transferase (GGT) increase with cholestasis, but their behavior differs by species. In dogs, ALP is highly sensitive for cholestasis because corticosteroid-induced and drug-induced isoenzymes add to the biliary isoenzyme. In cats, ALP has a short half-life and rises only modestly with cholestasis, so a marked increase in a cat is more concerning. In horses and ruminants, GGT is the more reliable cholestatic marker because ALP shows wide biological variation and bone isoenzyme contributions in growing animals.

The age-related changes in ALP in young animals deserve explicit attention. Growing calves, foals, and puppies have ALP activity two to three times adult reference intervals due to bone isoenzyme. Using adult reference intervals for juvenile animals produces false-positive cholestasis interpretations. The same principle applies to serum phosphorus, which runs higher in growing animals than in adults. Age-specific reference intervals are required for accurate interpretation in the first months of life, as demonstrated in Holstein dairy calves where ALP, AST, and inorganic phosphorus all showed significant age-related variation.

Mixed and Discordant Patterns

A mixed pattern with concurrent elevation of ALT and ALP is common and often reflects primary hepatocellular injury with secondary biliary compression from intrahepatic swelling. The dominant enzyme directs the next step. If ALT exceeds ALP by a wide margin, pursue hepatocellular causes: toxins, hypoxia, infectious hepatitis, and metabolic disease. If ALP predominates and ALT is near normal, pursue cholestatic causes: extrahepatic bile duct obstruction, cholelithiasis, pancreatitis, and infiltrative neoplasia.

A discordant pattern, where one enzyme is elevated and the other is normal, narrows the differential list. Isolated ALP elevation in a dog without clinical signs often reflects corticosteroid or anticonvulsant induction. Isolated GGT elevation in a horse suggests early biliary disease. Isolated ALT elevation in a cat should prompt investigation for inflammatory bowel disease and pancreatitis, which cause reactive hepatic changes.

Enzyme Induction and Non-Hepatic Sources

ALP and GGT are not liver-specific. Bone isoenzyme contributes in growing animals and with osteosarcoma. Corticosteroid-induced ALP in dogs is a distinct isoenzyme that rises within days of exogenous or endogenous glucocorticoid exposure. Intestinal isoenzyme contributes minimally in most species. AST is present in skeletal muscle and cardiac muscle, so concurrent creatine kinase (CK) measurement distinguishes muscle from hepatic sources. An elevated AST with normal CK points to the liver. Elevated AST with elevated CK indicates muscle injury, and the hepatic component cannot be assessed until the muscle source resolves.

Kidney Values: Distinguishing Prerenal, Renal, and Postrenal Azotemia

The kidney profile, urea nitrogen and creatinine, requires concurrent urine specific gravity and urine output assessment. The three categories of azotemia are distinguished by these ancillary data, not by the magnitude of the biochemical changes alone.

Prerenal Azotemia

Prerenal azotemia results from decreased renal perfusion with preserved renal function. The kidneys concentrate urine normally, so urine specific gravity exceeds 1.030 in dogs and 1.035 in cats when azotemia is present. The urea nitrogen to creatinine ratio is often increased because urea is more affected by reduced glomerular filtration and increased tubular reabsorption in hypoperfusion. Dehydration, hypovolemia, and reduced cardiac output are the usual causes. The azotemia corrects within 24 to 72 hours of fluid therapy if the underlying perfusion deficit is treated.

Renal Azotemia

Renal azotemia reflects loss of functional nephron mass. The kidneys cannot concentrate urine, so urine specific gravity is in the isosthenuric range, 1.008 to 1.012, or minimally concentrated. The diagnosis requires that the urine sample be obtained before fluid therapy, because fluid administration lowers urine specific gravity and confounds the assessment. The magnitude of creatinine elevation correlates with the percentage of functional nephron loss. A creatinine increase from 1.5 to 3.0 mg/dL in a dog represents substantial loss of renal reserve, because the relationship between creatinine and glomerular filtration rate is curvilinear.

Postrenal Azotemia

Postrenal azotemia arises from obstruction or rupture of the urinary tract. The kidneys retain concentrating ability early in obstruction, but chronic obstruction damages tubular function. Urethral obstruction, ureteral obstruction, and urinary bladder rupture produce postrenal azotemia. Rupture is distinguished by the presence of peritoneal fluid with creatinine concentration higher than peripheral blood creatinine. The ratio of peritoneal fluid creatinine to serum creatinine exceeds 2:1 in uroabdomen.

Breed and Physiologic Variation

Creatinine is influenced by muscle mass. Greyhounds and other sighthounds have higher baseline creatinine concentrations than other breeds, and their serum biochemistry results can appear abnormal when judged against general canine reference intervals. A healthy retired racing Greyhound with a creatinine of 1.8 mg/dL may have normal renal function. The same value in a breed with lower muscle mass warrants investigation. This breed-specific variation requires interpretation against breed-specific reference data where available.

Electrolyte Abnormalities: Pattern-Based Correction

Electrolyte disturbances rarely present in isolation. The pattern of concurrent changes identifies the underlying disorder more reliably than any single value.

Sodium and Chloride

Hyponatremia with hyperkalemia points to hypoadrenocorticism in dogs, particularly when the sodium to potassium ratio falls below 27:1. This pattern also occurs with severe gastrointestinal loss, chylothorax, and trichuriasis. The distinction requires an ACTH stimulation test, because the treatment differs substantially.

Hyponatremia with normal potassium suggests water excess relative to sodium. This occurs with psychogenic polydipsia, syndrome of inappropriate antidiuretic hormone secretion, and advanced renal failure. Hypernatremia with hyperkalemia suggests water loss exceeding sodium loss, as in diabetes insipidus or inadequate water intake. Hypernatremia with hypokalemia occurs with primary hyperaldosteronism, a rare but reported condition in cats.

Potassium

Hypokalemia in cats is a common finding with chronic kidney disease, particularly when the cat is polyuric. The renal loss is exacerbated by metabolic acidosis, which shifts potassium into cells. Hypokalemia also causes a myopathy that can be mistaken for neuromuscular disease. The severity of hypokalemia guides the urgency of replacement, and current formulary references must be consulted for specific rates and routes.

Hyperkalemia with metabolic acidosis occurs with renal failure, uroabdomen, and hypoadrenocorticism. The acid-base disturbance shifts potassium extracellularly, and the electrocardiographic changes, peaked T waves and bradycardia, require immediate attention. The strong ion approach to acid-base interpretation has been evaluated in dogs, and while the prognostic value of these systems is limited, the association between acid-base disturbances and mortality supports careful integration of electrolyte and acid-base data.

Calcium and Phosphorus

Hypercalcemia with normal or low phosphorus suggests malignancy, primary hyperparathyroidism, or granulomatous disease. Hypercalcemia with hyperphosphatemia suggests renal failure, hypoadrenocorticism, or vitamin D toxicosis. The calcium to phosphorus product guides the risk of soft tissue mineralization. Hypocalcemia with hyperphosphatemia occurs with ethylene glycol toxicosis and acute kidney injury. Hypocalcemia with hypophosphatemia occurs with nutritional secondary hyperparathyroidism and malabsorption.

The Problem-Oriented Biochemistry Algorithm

The following algorithm integrates the patterns described above into a sequence that can be applied to any biochemistry panel.

Documentation and Monitoring

The biochemistry panel is a point-in-time measurement. Documentation must include the laboratory reference interval, the analyzer used, and the patient's signalment, because all three affect interpretation. Serial monitoring requires the same laboratory and analyzer to avoid introducing analytical variation. The biological variation of many measurands in horses, including total protein, globulins, albumin, and GGT, is high between individuals, which supports the use of individualised reference intervals for monitoring individual patients over time.

Monitoring intervals depend on the clinical trajectory. Acute hepatocellular injury warrants repeat biochemistry in 48 to 72 hours. Chronic kidney disease warrants recheck in 2 to 4 weeks after therapeutic changes, then every 3 to 6 months. Electrolyte disturbances require more frequent monitoring during correction, and the frequency is guided by the severity of the initial disturbance and the patient's response.

The documentation should record the pattern identified, the differential list generated, the diagnostic plan, and the monitoring schedule. This structure supports continuity of care and provides a basis for reassessment when new information becomes available.

Recognized Complications and Failure Modes

Biochemistry panels fail clinically in predictable ways. The most consequential failure is the uncritical acceptance of a single abnormal value as disease. Analytical error, preanalytical hemolysis or lipaemia, and transient physiologic fluctuation all produce spurious abnormalities. The corrective discipline is repetition: confirm a clinically significant abnormality on a fresh sample before committing to invasive or costly investigation.

A second failure mode is pattern neglect. A mild increase in alanine aminotransferase (ALT) with a normal alkaline phosphatase (ALP) and bilirubin suggests a different process than the same ALT increase accompanied by hyperbilirubinaemia and prolonged clotting times. The clinician who interprets each analyte in isolation loses the diagnostic power of the panel.

A third failure mode is the overinterpretation of magnitude. A three-fold ALT increase and a thirty-fold ALT increase are not distinguished by the word "elevated." Magnitude, trajectory, and the presence of concurrent abnormalities determine urgency. Serial sampling is often more informative than a single measurement, particularly for distinguishing progressive from self-limiting processes.

A fourth failure mode is the application of adult reference intervals to juveniles. Age-related changes in serum proteins, phosphorus, alkaline phosphatase, and aspartate aminotransferase in growing calves are sufficiently large that age-specific reference values must be considered for precise interpretation. The same principle applies to foals, puppies, and kittens.

Common Errors and Corrective Action

Less experienced clinicians frequently mistake breed-specific variation for disease. Greyhounds, for example, have physiologic peculiarities that complicate laboratory interpretation, including a higher prevalence of hypertension and microalbuminuria in clinically healthy retired racing dogs than in other breeds. Hypertension in retired racing Greyhounds can contribute to microalbuminuria and renal histologic lesions, so a diagnosis of renal disease in this breed requires more than a positive dipstick for protein.

A second common error is interpreting a single post-exercise sample without accounting for exertion. Barrel racing significantly alters packed cell volume, hemoglobin, and plasma lactate immediately after exercise, with values returning toward baseline within 30 to 120 minutes. Exercise challenge significantly alters hematologic and biochemical variables in horses, so samples for baseline biochemistry should be collected before exertion or after an adequate rest period.

A third error is the assumption that population reference intervals apply equally to all individuals. Some measurands, including total protein, globulins, albumin, and gamma-glutamyl transferase in horses, demonstrate high individuality, meaning that a value within the population interval may still represent a significant change for a given animal. Subject-based reference intervals and reference change values are more appropriate for measurands with high individuality. Serial monitoring of an individual is often more informative than comparison with a population table.

A fourth error is the failure to integrate acid-base data with biochemistry. In critically ill dogs, acid-base disturbances carry prognostic information, but the predictive performance of any single calculated variable is limited. The prognostic ability of Henderson-Hasselbalch, Stewart, and semi-quantitative acid-base methods was similar and modest in dogs. The clinician should treat acid-base derangements as one component of a broader assessment, not as a standalone prognostic test.

Limitations of the Evidence and Areas of Expert Disagreement

The evidence base for biochemistry interpretation rests heavily on population-derived reference intervals that vary by laboratory, analyzer, and methodology. The American Society for Veterinary Clinical Pathology provides quality assurance and laboratory standards guidance for reference interval generation and method validation, but adoption is voluntary and intervals are not universally harmonised. Clinicians should use intervals supplied by their own laboratory whenever possible.

Expert opinion diverges on several practical points. The clinical significance of mild, persistent enzyme increases without histologic confirmation remains contested. Some specialists recommend liver biopsy for any persistent ALT increase beyond two to three times the upper reference limit, others reserve biopsy for cases with concurrent functional impairment, such as hyperbilirubinaemia or decreased bile acid clearance. The role of serum triglycerides and total proteins as nutritional biomarkers is established in some species, such as the use of total serum proteins and triglycerides for monitoring body condition in the Iberian wild goat, but extrapolation to domestic species requires caution.

Referral, Consultation, and Reporting

Referral is warranted when the biochemistry pattern suggests a process beyond the scope of primary care, when serial monitoring shows progression despite treatment, or when the diagnostic plan requires advanced imaging, biopsy, or specialised laboratory testing. Specialist consultation is appropriate for persistent electrolyte derangements, unexplained azotemia with abnormal urine findings, and suspected endocrine or paraneoplastic syndromes that require confirmatory assays.

Laboratory involvement is indicated when results are inconsistent with the clinical picture, when a critical value is reported, or when sample quality is questionable. The laboratory should be contacted directly instead of repeating the test blindly.

Regulatory reporting obligations vary by jurisdiction and production system. The World Organization for Animal Health terrestrial animal health standards define notifiable diseases that may present with characteriztic biochemistry abnormalities, and the American Veterinary Medical Association provides practice resources on professional obligations. Clinicians must know the reporting requirements for their region and species. When in doubt, consultation with the relevant authority is preferable to non-reporting.

Frequently Asked Questions

How Should I Interpret Biochemistry Results When the Laboratory Reference Interval Differs From Published Values?

Laboratory-specific reference intervals should take precedence over published values, provided the laboratory follows current validation standards. The American Society for Veterinary Clinical Pathology quality assurance guidelines recommend that each laboratory establish or verify intervals for its own analyzer and population. When a result falls outside the laboratory interval but within a published interval, recheck the sample and review the analyzer's calibration records. Age-specific intervals matter in growing animals, as demonstrated in Holstein calves where several analytes changed significantly during the first three months of life. If the laboratory cannot provide species-specific intervals, request that the reference laboratory supply its validation data before interpreting borderline results.

What Biochemistry Panel Is Appropriate When Cost Limits the Testing Options?

Prioritize analytes that answer the specific diagnostic question. For suspected hepatic disease, measure alanine aminotransferase, alkaline phosphatase, total bilirubin, and fasting bile acids. For renal disease, measure creatinine, urea, phosphorus, and total protein, then add urinalysis. A minimum electrolyte panel of sodium, potassium, and chloride is justified when vomiting, diarrhea, or diuretic therapy is present. Avoid reflexively adding analytes that will not change management. When a full panel is unaffordable, the MSD Veterinary Manual provides guidance on which single tests carry the highest diagnostic yield for common presentations. Document the testing limitation in the medical record and state which differentials remain unresolved because of the reduced panel.

How Do I Interpret Biochemistry Results in a Species With Known Physiologic Peculiarities?

Breed and species peculiarities can invalidate routine interpretation. Greyhounds, for example, have higher creatinine concentrations than other breeds despite normal renal function, and hypertension in retired racing Greyhounds is common even when serum biochemistry results are normal. In horses, several measurands including total protein, globulins, and gamma-glutamyl transferase show high individuality, meaning a single result within the population interval may still represent a significant change for that individual. Subject-based reference intervals and reference change values are more appropriate for such measurands. Consult species-specific references and, when available, breed-specific data before interpreting borderline values. Serial sampling to establish an individual baseline is often more informative than a single comparison with a population interval.

What Should I Do When Point-of-Care Biochemistry Results Disagree With the Reference Laboratory?

Repeat the point-of-care test using a fresh sample and verify the analyzer's quality control results. Check the sample for hemolysis, lipaemia, or icterus, as these interfere with many dry-slide and handheld analyzers. If the discrepancy persists, submit a paired sample to the reference laboratory and document both results in the record. Point-of-care analyzers are calibrated for specific species and may perform poorly on others. The ASVCP quality assurance guidelines address method validation and recommend that any analyzer used for clinical decisions have verified performance for the target species. Do not disregard a reference laboratory result solely because it conflicts with point-of-care testing, but do investigate preanalytical causes before acting on either value.

How Should I Document Biochemistry Interpretation in the Medical Record?

Record the clinical question that prompted testing, the relevant results with laboratory reference intervals, the pattern identified, and the differential diagnoses generated. State which results are unexplained and what follow-up is planned. Include the timing of sampling relative to drug administration, fluid therapy, or exercise, since these affect many analytes. In horses, for example, barrel racing exercise significantly alters packed cell volume, lactate, and other parameters immediately after exertion, so sampling time must be recorded. If a result is interpreted as an artefact, document the basis for that conclusion. This record supports continuity of care and defensible decision-making if the case is reviewed later.

How Do I Explain Confusing Biochemistry Results to a Client or Referring Veterinarian?

Frame the explanation around the clinical question instead of the individual numbers. State what the panel was intended to rule out, what patterns were present, and what the next diagnostic step will be. Acknowledge that some results fall outside the reference interval without indicating disease, and that serial monitoring may be needed to distinguish transient change from progressive disease. For referring veterinarians, provide the specific pattern recognized, the differentials ranked by likelihood, and the recommended next tests. The AVMA practice resources offer communication guidance for discussing diagnostic uncertainty with clients. Avoid overstating the certainty of a biochemistry-based diagnosis and be explicit about which conditions remain possible despite normal results.

Related Clinical & Scientific Guides

• Peripheral Blood Smear Evaluation: A Step-by-Step Guide
• Reticulocyte Counts in Veterinary Medicine: Clinical Utility and Interpretation
• Cerebrospinal Fluid Analysis in Veterinary Neurology: Collection and Interpretation

References and Further Reading

• Hematology and serum biochemistry of Holstein dairy calves: age related changes and comparison with blood composition in adults.. 2007.
• Evaluation of the association between strong ion acid-base disturbances and mortality in dogs: a retrospective study.. 2018.
• The use of total serum proteins and triglycerides for monitoring body condition in the Iberian wild goat (Capra pyrenaica).. 2008.
• Arterial blood pressure, proteinuria, and renal histopathology in clinically healthy retired racing greyhounds.. 2012.
• Effects of 3-Barrel Racing Exercise on Electrocardiographic and on Blood Parameters of Quarter Horses. 2016.
• Biological variation of routine hematology and biochemistry measurands in the horse.. 2019.
• American Society for Veterinary Clinical Pathology Guidelines. American Society for Veterinary Clinical Pathology.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.
• American Veterinary Medical Association Practice Resources. American Veterinary Medical Association.

Related Articles

• Interpreting the Canine CBC: A Diagnostic Approach
• Urinalysis in Veterinary Practice: From Collection to Interpretation
• Cytology of Joint Fluid: Collection and Interpretation in Arthropathies
• Cytology of the Liver and Spleen: Diagnostic Utility and Interpretation
• Cytology of the Respiratory Tract: Collection and Interpretation

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.